Issuance of Stock Acquisition Rights to Directors
First written in FY2019-Q2. 10 of 11 entries say "Advanced", first in FY2020-Q2. Latest entry: 2026-07-08.
- FY2026-H1AdvancedAnnual report
「Resolution date: 20 June 2025. Category and number of eligible recipients (people): 6 directors (excluding outside directors). Number of stock acquisition rights (rights): * 613. Class of shares underlying the stock acquisition rights: * common shares. Number of shares underlying the stock acquisition rights (shares): * 61,300. Amount payable upon exercise of the stock acquisition rights (yen): * 1. Exercise period of stock acquisition rights: * 8 July 2025 to 7 July 2075」
The company issued 613 stock acquisition rights and 61,300 underlying shares to 6 directors excluding outside directors, with an exercise period of 8 July 2025 to 7 July 2075. - FY2025-H1AdvancedAnnual report
「The stock acquisition rights issued during the interim accounting period were as follows. Resolution date: 21 June 2024. Category and number of eligible recipients (people): Directors (excluding outside directors), 6. Number of stock acquisition rights (rights): * 561. Class of shares underlying the stock acquisition rights: * common shares. Number of shares underlying the stock acquisition rights (shares): * 56,100. Amount payable upon exercise of the stock acquisition rights (yen): * 1. Exercise period of stock acquisition rights: * 9 July 2024 to 8 July 2074」
The company issued 561 stock acquisition rights and 56,100 underlying shares to 6 directors excluding outside directors. The exercise period was stated as 9 July 2024 to 8 July 2074. - FY2024-Q2AdvancedAnnual report
「Resolution date: 22 June 2023. Category and number of eligible recipients (people): 5 directors (excluding outside directors). Number of stock acquisition rights (rights): * 570. Class of shares underlying the stock acquisition rights: * common shares. Number of shares underlying the stock acquisition rights (shares): * 57,000. Amount payable upon exercise of the stock acquisition rights (yen): * 1. Exercise period of stock acquisition rights: * 8 July 2023 to 7 July 2073」
The company issued 570 stock acquisition rights and 57,000 underlying shares to 5 directors excluding outside directors. - FY2023-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. Resolution date: 23 June 2022. Category and number of eligible recipients (people): Directors (excluding outside directors), 6. Number of stock acquisition rights (rights): * 638. Number of shares underlying the stock acquisition rights (shares): * 63,800. Exercise period of stock acquisition rights: * 9 July 2022 to 8 July 2072」
The company issued 638 stock acquisition rights and 63,800 underlying shares to 6 directors excluding outside directors. - FY2022-Q2AdvancedAnnual report
「Resolution date: 23 June 2021. Category and number of eligible recipients (people): Directors (excluding outside directors), 7. Number of stock acquisition rights (rights): * 731. Number of shares underlying the stock acquisition rights (shares): * 73,100. Exercise period of stock acquisition rights: * 9 July 2021 to 8 July 2071」
The company issued 731 stock acquisition rights and 73,100 underlying shares to 7 directors excluding outside directors. - FY2021-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows. Resolution date: 23 June 2020. Category and number of eligible recipients (people): Directors (excluding outside directors), 7. Number of stock acquisition rights (rights): * 795. Number of shares underlying the stock acquisition rights (shares): * 79,500. Exercise period of stock acquisition rights: * 9 July 2020 to 8 July 2070」
For the stock acquisition rights for directors resolved in FY2020, 795 rights and 79,500 underlying shares were issued and the exercise period was finalized in the second-quarter report. - FY2020AdvancedAnnual report
「Resolution date: 23 June 2020. Category and number of eligible recipients (people): 7 directors (excluding outside directors). Number of stock acquisition rights (rights): 795. Number of shares underlying the stock acquisition rights (shares): 79,500」
By the filing date, a resolution to issue 795 stock acquisition rights and 79,500 underlying shares to 7 directors excluding outside directors had been disclosed. - FY2020-Q2AdvancedAnnual report
「Category and number of eligible recipients (people): Directors (excluding outside directors), 7. Number of stock acquisition rights (rights): * 788. Number of shares underlying the stock acquisition rights (shares): * 78,800. Exercise period of stock acquisition rights: * 6 July 2019 to 5 July 2069」
The company issued 788 stock acquisition rights and 78,800 underlying shares to 7 directors excluding outside directors. - FY2019-Q2First statedAnnual report
「Category and number of eligible recipients (people): Directors (excluding outside directors), 7. Number of stock acquisition rights (rights): * 705. Number of shares underlying the stock acquisition rights (shares): * 70,500. Exercise period of stock acquisition rights: * 7 July 2018 to 6 July 2068」
During the second quarter accounting period, 705 stock acquisition rights and 70,500 underlying shares were issued to 7 directors excluding outside directors. The exercise period was stated as 7 July 2018 to 6 July 2068.